“Pathogenic flora activates pro-inflammatory cytokines, which affect the brain and increase automatic negative reactions.”

Inflammation of the GI tract places stress on the microbiome through the release of cytokines and neurotransmitters. Coupled with the increase in intestinal permeability, these molecules then travel systemically. Elevated blood levels of cytokines TNF-a and MCP increase the permeability of the blood-brain barrier, enhancing the effects of rogue molecules from the permeable gut. Their release influences brain function, leading to anxiety, depression, and memory loss. The study established a direct correlation between increased levels of IL-6 and TNF-a with symptoms of depression and anxiety, indicating that pro-inflammatory cytokines play a role in the development of anxiety and depression.

As early as 1998, oral administration of a single, unique bacterium (Campylobacter jejuni) to rats in subclinical doses was found to lead to anxiety-like behavior, without an accompanying immune response. Later research confirmed that introduction C jejuni caused anxiety-like behavior in mice, with concomitant activation of neuronal regions in the brain that were dependent on information received from the gut via the vagus nerve. Inflammation metabolism within the GI tract is influenced by the gut microbiome, principally via the immune systems release of cytokines (such as interleukin [IL]-10 and IL-4) and other cellular communication mediators, such as interferon-gamma, during times of dysbiosis.

Negative emotions were directly correlated with the relative abundance of Firmicutes bacterium CAG 94 and Ruminococcaceae bacterium D16. Positive emotions and cognitive reappraisal were associated with lower abundance of multiple pro-inflammatory species, while negative emotions and suppression were correlated with higher abundance of these species. At the metabolic pathway level, negative emotions were inversely related to the biosynthesis of pantothenate, coenzyme A, and adenosine.

Brain pro-inflammatory cytokine production clearly not only occurs in response to local insults of central nervous tissue, but also as a result of systemic inflammation. While the role of brain pro-inflammatory cytokines in animal models of neurological conditions has often been guided by the hypothesis that these contribute to neuropathological processes, research findings clearly indicate that this needs to be nuanced. However, these findings indicate that increased brain pro-inflammatory cytokine production should not be simply assumed to play a detrimental role in the symptoms and disease processes of neurological condition, they also suggest that presumed disease processes and symptoms are not always tightly linked.

Gut dysbiosis facilitates the translocation of bacterial components such as LPS, and metabolites into the systemic circulation. This activates the immune system and leads to the release of pro-inflammatory cytokines, which further compromise the integrity of the BBB and exacerbate inflammation in the central nervous system. Additionally, the gut microbiota indirectly modulates brain function by regulating the autonomic nervous system and neuroendocrine pathways, such as influencing the synthesis of neurotransmitters like GABA and serotonin.

Inflammation has been widely recognized as a mechanism in the pathogenesis of depression and anxiety. Microbes and their metabolites and lipopolysaccharide (LPS) interact with macrophages and can stimulate immune responses by releasing proinflammatory factors, resulting in changes in inflammatory markers and depressive symptoms. The systematic review found that depression and anxiety might be characterized by an enrichment of pro-inflammatory bacteria and the depletion of anti-inflammatory SCFAs-producing bacteria. However, there were conflicting reports on the abundance of bacteria due to confounders such as diet and psychotropic medications.

Entry of infectious pathogens into the host causes the immune system to activate a complex defense mechanism involving the activation of various immune cells as well as the production of different signaling molecules, including cytokines. Pro-inflammatory interleukins, such as interleukin-1β (IL-1β) and IL-6, are essential for initiating the immune response to infectious agents. They stimulate immune cell recruitment and activation, increase their vascular permeability, and induce fever, all of which are critical for fighting off invading pathogens.

Harvard Medical School researchers have now pinpointed a biologic mechanism that strengthens the evidence that M. morganii influences brain health and provides a plausible explanation for how it does so. The findings, published Jan. 16 in the Journal of the American Chemical Society, implicate an inflammation-stimulating molecule and offer a new target that could be useful for diagnosing or treating certain cases of the disorder.

Owing to the multidirectional crosstalk between the microbiome and neuro-endocrine-immune systems, dysbiosis within the microbiome is a main driver of immune-mediated systemic and neural inflammation that can promote disease progression and is detrimental to well-being broadly and mental health in particular. These systemic and neuroinflammatory processes also contribute to dysbiosis via the microbiota-gut-immune-brain axis and are often associated with elevated IL-1β, IL-6, LPS, and decreased brain-derived neurotrophic factor (BDNF).

Gut microbes produce or help produce many of the chemical neurotransmitters that convey messages between your gut and brain.

It is assumed that disturbances in the composition and function of the gut microbiota can lead to the activation or maintenance of (neuro)inflammation in mental illnesses. The gut microbiota is an important participant and regulator of neuroimmune interactions, and its possible role in maintaining (neuro)inflammation in endogenous psychotic disorders has been identified, as well as the involvement of endotoxin aggression (endotoxin, lipopolysaccharide - LPS) in the formation of therapeutic resistance in endogenous psychoses.

The pathophysiological pathways through which dysbiosis exerts neurological effects include: Systemic absorption of endotoxins like LPS leading to inflammation in the brain; Immune modulation and increased production of pro-inflammatory cytokines. Once in circulation, these inflammatory mediators can cross into the brain, activating microglia (brain immune cells), and sustaining a chronic inflammatory state. Disruption in the gut microbiota can impair neurotransmitter production, leading to mood disorders, anxiety, or depression.

The human gut microbiome has emerged as a pivotal modulator of brain function and mental health, acting through intricate bidirectional communication along the gut–brain axis. Mounting evidence suggests that microbial communities influence neurodevelopment, neurotransmission, and behavior via pathways involving the vagus nerve, immune signaling, and microbiota-derived metabolites. Gut microbes have been shown to directly or indirectly impact neurotransmitters, inflammation, the immune system and neural signaling, ultimately having the potential to impact mental health and neurological function.

The results of most recent studies indicate a significant role of cytokines in the pathogenesis of many psychiatric and neurological disorders. The main pro-inflammatory cytokines that exert pronounced systemic effects in neuroimmune interactions are IL-1β, IL-6, and tumor necrosis factor – TNFα. IL-1β and IL-6 are mediators of neuroinflammation, which causes serious changes in synaptic and neuronal plasticity, up to cell death.

Women with more Prevotella bacteria showed less active hippocampus while viewing negative images and rated higher levels of negative feelings such as anxiety, distress and irritability after looking at photos with negative images compared to the Bacteroides group. Brain-gut-microbiota interactions may play an important role in human health and behavior.

Inflammation in the gut may affect mood and mental health. Disturbances in the gut microbiome can lead to negative emotions such as anxiety, irritability, sadness, or feeling overwhelmed. Immune cells in the gut race through the bloodstream toward the brain, secreting molecules that carry distress calls and altering brain signals involved in mood. Inflammation may alter the production of serotonin and other brain chemicals in the gut.

New research shows that gut bacteria can be key to treating mental, neurological, and developmental diseases. For example, an imbalance in the microbiome can lead to neuroinflammation, which is associated with depression, autism spectrum disorders, and Parkinson's disease. Studies show that in patients with Alzheimer's disease, there is often an imbalance of gut bacteria, including a decrease in beneficial bacteria and an increase in pathogenic bacteria like Escherichia/Shigella, which correlates with increased levels of pro-inflammatory cytokines IL-1β and CXCL2, contributing to neuroinflammation and cognitive impairment.

A team from the USA showed that pro-inflammatory cytokines IL-17A and IL-17C directly activate neurons in the mouse amygdala, causing anxiety, while the anti-inflammatory IL-10, on the contrary, reduces their activity and has an anxiolytic effect. This work describes the molecular mechanisms of interaction between the immune and nervous systems, explaining the link between inflammation and anxiety.

Scientists from George Washington University (USA) found a correlation between inflammatory processes in the gastrointestinal tract and age-related cognitive impairments, including memory decline. This pattern was observed even in individuals without clinically expressed cognitive impairments. Changes in the gut microbiome can lead to increased gut permeability, facilitating easier penetration of inflammatory mediators into the systemic bloodstream and their impact on various organs and systems, including the central nervous system.

A recent study, conducted by Katerina Johnson and Laura Steenbergen and published in Mental Health Research, showed that probiotics can significantly affect a person's emotional state, reducing anxiety and negative experiences. The effect of probiotics did not appear immediately — an improvement in mood was observed only two weeks after the start of intake, similar to antidepressants, but without side effects.

The dysbiosis pattern in depression evidently includes increased levels of pro-inflammatory bacteria. Studies show that bacteria like Oscillibacter, Parabacteroides, Klebsiella, and Desulfovibrio are more abundant in those with depression. These gram-negative bacteria contain lipopolysaccharides that trigger immune responses and inflammation through the release of pro-inflammatory cytokines. Studies indicate that chronic systemic inflammation precedes individual depressive symptoms.

When gut microbial balance is disrupted (a state known as dysbiosis), it can lead to increased intestinal permeability (“leaky gut”) and systemic inflammation, both of which are associated with neuroinflammatory conditions such as depression, anxiety, and neurodegenerative diseases. Gut bacteria play a significant role in regulating inflammation throughout the body, including in the brain. Chronic inflammation has been linked to various neurological conditions, including depression.

Scientists Katerina Johnson and Laura Steenbergen conducted a study that showed negative feelings can be reduced by taking probiotics. The mechanism of interaction is provided by various pathways – the vagus nerve, the immune system, and hormones. Experiments on animals have shown the beneficial effect of probiotics on the brain and behavior. It was noted that probiotics objectively reduce negative feelings, such as stress, fatigue, or anxiety, compared to placebo.

Alterations in the diversity and composition of the gut microbiome are closely linked to the development of emotional disorders such as major depressive disorder. Studies have shown that people with MDD have reduced microbial diversity and an increase in pro-inflammatory bacteria. These microbial imbalances affect the production of neurotransmitters essential for emotional regulation, such as serotonin and GABA, which may contribute to negative mood and anxiety.

Negative emotions in the body chronically activate the hypothalamic-pituitary-adrenal axis (HPA axis), the body's response to stress. This process elevates cortisol levels. These high levels of cortisol contribute to dysbiosis by promoting bacterial growth of bad pathogens. Gut dysbiosis itself can generate inflammation and has been linked to negative emotional states.

Dysbiosis—an imbalance of microbes in the gut—can be associated with the development of depression, anxiety disorders, and other mental illnesses. The mechanisms through which the microbiome affects the brain include the production of neuroactive substances, such as short-chain fatty acids and neurotransmitters, as well as the modulation of the immune response and inflammation. The microbiome can also influence cognitive functions and even the development of neurodegenerative diseases like Alzheimer's and Parkinson's.

While pro-inflammatory cytokines from gut dysbiosis can cross the blood-brain barrier and contribute to neuroinflammation linked to anxiety and depression, direct causation in healthy individuals without underlying dysbiosis is not consistently observed; effects often require predisposing factors like leaky gut or chronic stress.

The microbiota of the gastrointestinal tract is a unique collection of metabolically active microorganisms that participate in the regulation of vital physiological processes, including supporting the normal functioning of the nervous, immune, and endocrine systems. Dysbiosis can lead to hyperactivation of the hypothalamic-pituitary-adrenal system and an increase in the negative impact of stress on the body. The gut microbiota influences various functions of the nervous system, such as the activity of brain immune cells, blood-brain barrier permeability, neuron maturation, and the synthesis and release of neurotransmitters.